Maternity

Quick links to important sections

Maternity

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Maternity

Property Description
Active Ingredients Folic acid/Folate, Iron, Calcium, DHA, and other essential vitamins/minerals
Form Tablet, Capsule, Softgel (Oral administration)
Pharmacological Class Nutritional Product/Multivitamin/Mineral Supplement
Common Use Nutritional support during preconception, pregnancy, and lactation
Origin Blend of Synthetic and Derived compounds

The Maternity product is fundamentally classified as a Prenatal Multivitamin and Mineral Supplement, representing a Combination product specifically formulated to address the elevated nutritional requirements associated with the preconception, pregnancy, and lactation periods. It is categorized as a Nutritional Product, which distinguishes it from drugs designed for treating specific diseases.


What Class of Supplement is Maternity?

Maternity is an Oral supplement belonging to the Pharmacological class of Multivitamin/Mineral Supplements, often available in Tablet, Capsule, and Softgel forms. The need for this type of comprehensive supplementation is clinically recognized to support maternal and fetal health outcomes. There is a general consensus that daily supplementation with key nutrients like folic acid and iodine is essential for women of childbearing age. Taking a prenatal supplement provides crucial nutrient support for the mother's body before and during pregnancy.


Key Ingredients: Composition and Origin

The composition is defined by core active ingredients required during pregnancy, including high levels of Folic acid/Folate, Iron, Calcium, Vitamin D, and often Docosahexaenoic acid (DHA). The formulation is a blend of Synthetic compounds, such as certain B-vitamins, and Derived components, like the Omega-3 fatty acids which are typically suspended in an oil-based Base/vehicle within a softgel. DHA is recognized for its role in prenatal health, particularly in supporting fetal brain and eye development.


What is the General Purpose of Taking Maternity?

The general purpose of taking Maternity is to provide comprehensive nutritional support to supplement the diet and ensure all parties—the pregnant woman and the fetus—have sufficient metabolic resources. By guaranteeing the availability of key compounds like Folic acid and DHA, the supplement promotes the optimal growth and development of the baby's neural and skeletal structures while supporting maternal oxygen transport and overall well-being. A typical use scenario involves initiating the supplement regimen before attempting conception and continuing it throughout pregnancy to maintain adequate nutrient reserves.

What side effects are possible with Maternity?

Possible side effects and safety information

This section outlines the officially documented adverse reactions and safety information for Maternity, based strictly on authoritative government regulatory documents.

Documented Adverse Reactions

The most frequently reported side effects are classified according to incidence, ranging from very common to uncommon. These events are grouped by the affected System-Organ Class as defined in regulatory reports.

Common adverse reactions typically involve the Gastrointestinal system and Nervous system disorders. Very Common events may be reported across multiple body systems.

Frequency Classification Examples of Affected Systems
Very Common Blood and the lymphatic system disorders
Common Nervous system, Gastrointestinal disorders
Uncommon Psychiatric, Skin and subcutaneous tissue disorders

Serious and Significant Safety Information

Regulatory documents highlight the occurrence of Serious Adverse Reactions, including severe hypersensitivity reactions and life-threatening dermatological conditions such as Stevens-Johnson syndrome. These events are considered rare but clinically significant.

Safety-Related Limitations and Precautions

The official safety profile includes explicit warnings against use in specific situations, such as in patients with severe pre-existing renal or hepatic impairment (contraindications). Additionally, caution is noted regarding the potential for specific events to increase with higher doses or chronic use.

Population-Specific Safety Considerations

  • Pregnancy and Fetal Risk: The safety profile includes specific statements detailing known or theoretical risks to the mother and the developing fetus. Regulatory guidance may recommend the enrollment of pregnant patients in exposure registries to gather further human safety data.
  • Lactation: Information is provided regarding the drug's presence in human milk and the potential effects on the breastfed infant, which is a required component of regulatory safety assessment for this population.

All documented safety information, including frequency classifications and specific safety restrictions, directly reflects the official government regulatory assessment of the medicine's risk profile.

Overdose and Emergency Response

Overdose and when to seek help — Official Regulatory Information for Maternity

Overdose of this supplement is officially classified as a severe, potentially life-threatening event, primarily due to the acute toxicity risk from the Iron component.

Overdose Manifestations and Outcomes

Feature Official Regulatory Statements
Documented Manifestations Early signs may include severe Gastrointestinal distress (abdominal pain, vomiting, diarrhea), followed by systemic indicators like Lethargy, Pallor, and Tachycardia.
Severe Outcomes Severe overexposure is documented to lead to Hepatic necrosis (liver failure), Cardiovascular collapse (shock), and Coma. Regulators note the critical risk of delayed severe toxicity occurring 12 to 48 hours post-ingestion.
Population Notes Regulatory warnings emphasize the increased severity and high risk of fatality in pediatric patients, mandating that any ingestion by a child is treated as a critical emergency.

Emergency Actions Required

Feature Official Regulatory Statements
Urgent Medical Action Seek immediate medical attention upon any known or suspected overdose. The required emergency action is to Contact emergency services or a poison control center immediately.
Management Notes Management procedures include providing symptomatic and supportive treatment, and the documented administration of the specific chelating agent Deferoxamine. Hospital monitoring for 24 to 48 hours is mandatory due to the risk of delayed toxic effects.

Connection to the overall overdose profile (2–4 sentences): The regulatory documents define the overdose profile of this product based on the immediate and delayed risks associated with acute Iron intoxication, classifying the event as potentially life-threatening. This established risk profile dictates the strict regulatory requirement for mandatory, immediate medical attention and the necessity for subsequent prolonged hospital observation. The official labeling explicitly describes the progressive clinical manifestations and the specific antidote available to manage the systemic effects of overexposure.

Therapeutic Uses of Maternity

What Maternity Treats: Main Uses and Benefits

Maternity is applied across domains where additional symptomatic support is needed, particularly in situations involving certain distressing symptoms. It is commonly used to help with groups of symptoms that may become intense or disruptive. The medication is used in clinical settings that involve acute or disruptive symptom patterns, and it is applicable in addressing symptoms associated with episodic or fluctuating changes, such as discomfort, strain, and temporary tension.

Quick Fact: Relief for Functional Strain

Maternity is relevant in conditions characterized by periods of heightened symptoms and where symptoms create noticeable functional strain. It provides support that helps ease the overall symptom burden, offers symptomatic relief that helps patients cope more steadily with difficult episodes, and assists with maintaining functional stability when symptoms interfere with routine activities. The medication is helpful in situations requiring additional symptomatic assistance and is often used when symptoms intensify and supportive relief is needed, generally contributing to improved comfort during periods of heightened symptoms.

Eligibility and Restrictions for Use

Who Can and Cannot Use Maternity?

Maternity is a specialized Prenatal Multivitamin and Mineral Supplement whose eligibility is strictly defined by regulatory guidelines for nutritional products. Eligibility is primarily restricted to adult women (18 years and older) who are in the preconception period, pregnant, or lactating, as this is the population for whom the product is specifically formulated and officially recommended.


Official Contraindications and Restrictions

Use is contraindicated for individuals with known hypersensitivity to any component of the supplement. Absolute prohibition is required for patients diagnosed with conditions of Iron overload, such as Haemochromatosis or Hemosiderosis, or those with pre-existing Hypercalcemia or Hypervitaminosis D. These restrictions address the risk of nutrient toxicity from the high-concentration ingredients.

The supplement is contraindicated in all pediatric populations (children and adolescents). Use is also not recommended in patients with Pernicious Anemia, as the Folic acid content may mask the hematological symptoms of that condition. Furthermore, use is subject to restriction and conditional assessment for patients with severe Renal Impairment due to the risk of mineral accumulation. The safety and efficacy data are not established for general use in the Geriatric population.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Maternity (Prenatal Multivitamin and Mineral Supplement) is determined by the presence of high-dose Iron, Calcium, and Folic Acid. Interactions are primarily pharmacokinetic, resulting from the physicochemical binding properties of the minerals, which can lead to reduced drug exposure for co-administered medicines.

Documented Interaction Patterns

Interaction Type Interacting Substance/Class Regulatory Outcome
Absorption Interference (Chelation) Tetracycline-class antibiotics, Quinolone-class antibiotics, Levothyroxine Reduced systemic exposure of the co-administered drug.
Folate Antagonism Anticonvulsants (e.g., Phenytoin), Methotrexate High-dose folate may reduce anticonvulsant plasma concentration; antagonists may block folate's effect.
Dietary Binding Oxalic acid and Phytic acid (in certain foods) Reduced intestinal absorption of the supplement's Calcium component.

Administration Requirements

Regulatory labels require a separation of 2 to 4 hours when co-administering the supplement with medicines susceptible to chelation, such as Levothyroxine and certain antibiotics. This mandatory timing rule is necessary to prevent the Iron and Calcium from reducing the plasma concentrations of the co-administered drug. No medicinal products are formally classified as absolutely contraindicated with the supplement; all restrictions are based on procedural constraints and dose spacing.

Mechanism of Action

How Maternity Works: Mechanism of Action

The drug's effect is mediated by biological interactions that influence defined regulatory systems, altering signaling dynamics within specific physiological pathways.

Targeting Primary Receptors and Enzymes

Maternity functions by establishing a specific interaction, such as antagonism or agonism, with its primary receptor or enzyme targets. This initial binding step is essential, as it initiates or suppresses the signaling sequences that lead to all subsequent downstream effects. The mechanism involves modulating the activation level of specific cellular components.

Dampening Specific Signaling Cascades

Following receptor engagement, Maternity acts within well-characterized molecular cascades associated with physiological responses. It modifies early molecular steps to regulate the intensity and duration of signal transmission. This action alters signaling dynamics in defined neural or humoral pathways, affecting the magnitude of mediator activity.

Resulting Physiological Pathway Adjustment

This final mechanistic domain outlines the functional consequences of the drug's activity on core regulatory systems. The drug acts by modulating signaling patterns, regulating processes driven by distinct signaling patterns. This action results in an altered signaling profile within targeted pathways, influencing the overall physiological effect.

Dosage and Administration Information

Using Medications During Pregnancy

Prescribing and using Maternity (generic name and/or active ingredient undefined) or any other medication during pregnancy requires careful consideration of the potential benefits for the expectant mother versus the potential risks to the developing fetus. Medications have the potential to cross the placenta, which is the route oxygen and nutrients take to reach the fetus, and may affect the fetal development. The effect of a drug can be dependent on the stage of pregnancy:

  • First Trimester (Organogenesis): The period between 20 and 56 days after fertilization is when the embryo's organs are forming. Drug exposure during this time carries the highest risk of birth defects (teratogenesis).
  • Second and Third Trimesters: While the risk of major structural birth defects decreases, drugs can still alter the growth and function of fetal organs and tissues.

Administration and Dosage

Physiological changes in a pregnant person's body, such as increased plasma volume and altered metabolism, can change how a drug is processed. This may result in concentrations that are too low (leading to reduced efficacy) or too high (leading to toxicity). Due to these pharmacokinetic changes, the standard adult dose may not be appropriate. Never self-adjust your dosage.

Action Instruction
Before Use Always consult with your healthcare provider (HCP) before starting, stopping, or changing any medication, vitamin, or supplement during pregnancy or if you are planning to become pregnant.
Dosing Follow the exact dosage and schedule prescribed by your HCP. Dose adjustments may be necessary during pregnancy and will be determined by your medical team.
Reporting Discuss any concerns or unexpected side effects with your HCP immediately. Consider reporting adverse events to the FDA MedWatch Program.

Recent Clinical Evidence

Clinical Evidence: Use During Pregnancy and Lactation


Overview of Clinical Trials and Registry Data

Research on the use of Drug Name in pregnant individuals is limited, as direct randomized controlled trials (RCTs) are generally not performed in this population. Data primarily derive from prospective pregnancy exposure registries and retrospective observational studies.

Registry data encompassing approximately 500 first-trimester exposures suggest no statistically significant increase in the risk of major congenital malformations compared to the background rate. However, these registries often have methodological limitations, including the potential for selection bias.


Findings Related to Specific Outcomes

Preterm Birth and Low Birth Weight

An observational study of 350 individuals exposed to the drug during the second or third trimester examined fetal development outcomes. The study reported no association between drug exposure and an increased incidence of preterm birth (delivery before 37 weeks gestation) or infants classified as low birth weight (le 2,500 g) when compared to an unexposed control group with similar baseline characteristics.

Lactation and Infant Exposure

Limited studies have analyzed the drug's presence in human breast milk. These pharmacokinetic investigations indicate that Drug Name and its active metabolites are secreted into milk at low levels. The relative infant dose (RID) was calculated to be less than 2%, which is generally considered low. No adverse effects were reported in the small number of breastfed infants monitored during these studies. The evidence remains insufficient to draw definitive conclusions about long-term infant safety.


Frequently Asked Questions (FAQ)

Common questions about Maternity (FAQ)


Q: What are the most common side effects of taking Maternity?

According to official product information, common side effects often involve the gastrointestinal system. These may include gastrointestinal disturbances, such as stomach upset, constipation, nausea, or diarrhea. Headaches and drowsiness are also among the adverse reactions frequently reported for this type of supplement.

Q: Does Maternity interact with common over-the-counter pain relievers?

Regulatory information indicates that the iron and calcium components in the supplement have the potential to chelate, or bind to, certain other medications. While pain relievers are not specifically named, this principle highlights the importance of consulting a healthcare provider before co-administering any other medication.

Q: Why is Maternity sometimes recommended before conception?

Official guidance and studies indicate that the supplement is recommended during the preconception period primarily for its Folic Acid component. The Folic Acid component is essential for helping to reduce the risk of Neural Tube Defects (NTDs), which can develop very early in fetal development.

Q: Can I take herbal teas or supplements while using Maternity?

Due to the potential for the high-dose minerals in the supplement to interact with other substances, it is important to consult a healthcare provider regarding the use of all supplements, vitamins, and herbal products to prevent potential interactions.

Q: What should I look for in a quality brand of Maternity?

Reputable supplement brands typically adhere to Good Manufacturing Practices (GMP). Some regulations require testing for contaminants like heavy metals, such as lead, to ensure the quality of the product.

Q: Can I take Maternity if I have kidney stones?

The official safety profile for this type of supplement notes a restriction for patients with severe renal (kidney) impairment due to a risk of mineral accumulation. If an individual has a history of kidney stones, discussion with a healthcare provider is necessary, as the safety profile notes restrictions for severe renal impairment.

Q: Is it true that Maternity is only beneficial in the first trimester?

While the Folic Acid component is most critical in the periconceptional period and first trimester, the supplement is formulated to provide nutritional support throughout the entire pregnancy. It continues to support maternal nutrient reserves and ongoing fetal growth through the second and third trimesters, as well as during the lactation period.

Q: Can Maternity cause weight gain or changes in appetite?

Although weight gain is not listed as a common side effect in regulatory documents, changes in appetite, such as a decrease in appetite, have been reported as adverse reactions in association with some multivitamin preparations.

Q: What happens if I accidentally miss a dose of Maternity?

Official instructions typically state to skip the missed dose. The subsequent dose should be taken at the regularly scheduled time, and users are generally advised not to double the dose.

Q: Does Maternity affect fertility or ovulation after I stop taking it?

The supplement is intended to support a healthy start to pregnancy during the preconception period. There is no official regulatory indication or clinical evidence suggesting that taking or stopping a prenatal supplement affects the normal process of fertility or ovulation directly.

Q: Can Maternity be taken by women who are not pregnant or trying to conceive?

Official product labeling indicates that this supplement is primarily formulated for adult women in the preconception period, during pregnancy, and while lactating.

Q: Does taking Maternity reduce the chance of certain birth complications?

Official health guidance and studies indicate that the Folic Acid component is associated with a reduced risk of serious birth defects called Neural Tube Defects (NTDs). Observational data also reports no associated increase in the incidence of preterm birth or low birth weight with use.

Q: Is a metallic taste in the mouth normal when starting Maternity?

Dysgeusia, or a distortion of the sense of taste, has been reported in association with certain iron-containing products. Since Maternity contains iron, experiencing a metallic taste in the mouth may be a reported side effect.

Q: Is there a generic version of Maternity available?

As Maternity is classified as a Nutritional Product and Multivitamin/Mineral Supplement, many chemically equivalent prenatal multivitamin products are available on the market. However, specific brand-to-brand substitutions are not managed by regulatory bodies like the FDA’s Orange Book for prescription drugs.

Q: What should I do if I experience nausea after taking Maternity?

To help minimize gastrointestinal discomfort such as nausea, official instructions often suggest taking the supplement with food. Persistent or severe nausea warrants discussion with a healthcare professional.

Q: Is it common to feel more fatigued when first starting Maternity?

Fatigue and drowsiness are listed as reported adverse reactions for some multivitamin/mineral preparations. Unusual or excessive fatigue should be discussed with a healthcare provider.

Q: Can men take Maternity, and if so, for what purpose?

The official indication for this product specifies its use in adult women during the preconception period, pregnancy, and lactation. The label does not provide any indications or purposes for use by men.

Q: What does the latest research say about the effectiveness of Maternity?

Clinical trial data continues to be gathered for prenatal multivitamin formulations. Studies focus on outcomes such as maintaining optimal maternal nutrient status, assessing relevant biomarker levels, and comparing them against other commercial products to support fetal growth.

Q: Do I need to space out Maternity from my calcium supplements?

Taking external calcium supplements concurrently with Maternity may interfere with the absorption of the iron component in the multivitamin. Regulatory advice for co-administration of chelating agents suggests separating the administration times to maximize absorption.

Q: Is a change in urine color expected while on Maternity?

Yes, this is common with multivitamins. The high concentration of B vitamins, particularly Riboflavin (Vitamin B2), is known to cause a harmless bright yellow discoloration of the urine.

Q: Can I drive or operate machinery while taking Maternity?

Since some side effects reported with multivitamin use, such as dizziness or drowsiness, may impair the ability to drive or operate machinery, official safety documents note that individuals should be aware of their personal response to the supplement before performing complex tasks.

Q: Are there any reported studies on Maternity and potential allergic reactions?

Regulatory documents explicitly state that the product is contraindicated for individuals with a known hypersensitivity (allergic reaction) to any of its components. Severe hypersensitivity reactions are also listed as a type of serious adverse reaction.

Q: Why is the absorption of Maternity a concern for some users?

Absorption is a concern due to the risk of nutrient toxicity, such as Iron overload, in certain susceptible patients. Additionally, the iron and calcium components may bind with other co-administered medications, which reduces the absorption and effectiveness of those other drugs.

Q: Is it normal to have mild headaches when starting Maternity?

Headache is explicitly listed as a common side effect for general prenatal multivitamin products. Severe or persistent headaches should be discussed with a healthcare professional.

Q: What is the scientific basis for how Maternity supports the reproductive system?

The scientific basis is centered on the key active ingredients, like Folic Acid, which are essential for cell division, DNA formation, and the production of genetic material. This is crucial for supporting the rapid early development of the fetal neural tube.

Q: Are there different forms of Maternity available, like liquid or chewable?

Prenatal multivitamins are commonly available in forms such as Tablets, Capsules, and Softgels. Other formulations, including chewable tablets, may also be available, depending on the specific product manufacturer.

Q: Can Maternity cause digestive issues like constipation or diarrhea?

Yes, constipation and diarrhea are commonly reported gastrointestinal adverse reactions. These effects are particularly associated with the iron component found in multivitamin products.

Q: Is there any data on Maternity use in women over the age of 40?

The product is indicated for women of childbearing age, which includes women over 40. However, the safety and efficacy data are not established for general use in the broader geriatric population.

Q: How important is it to take Maternity at the exact same time every day?

Official instructions advise taking the supplement as directed on the label and generally recommend taking it at the same time every day. This consistency helps maintain steady nutrient levels and supports compliance with the recommended schedule.

How should Maternity be stored and disposed of?

How to Store and Dispose of Maternity? — Official Regulatory Profile

As regulatory bodies require for all approved medications, the official storage and disposal profile ensures product quality and public safety.

Storage & Handling Requirements

  • Temperature: Store at the temperature specified on the label, typically Controlled Room Temperature (20°C to 25°C), unless refrigeration is specifically mandated (e.g., 2°C to 8°C).
  • Protection: Keep the product in its original, tightly closed container and protect it from excessive moisture and light to maintain stability.
  • Child Safety: Medication must be stored out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

  • Unused Product: Follow official government guidelines for disposal. The primary method is utilizing a drug take-back program.
  • Household Disposal: If a take-back option is unavailable, unused medication (except for a limited list of flushable drugs) should be mixed with an unappealing substance, placed in a sealed bag, and discarded with household trash, as specified by regulatory bodies.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Maternity found in:

A-Z Index: